ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IMUN Immune Therapeutics Inc (PK)

0.093
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Immune Therapeutics Inc (PK) USOTC:IMUN OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.093 0.072 0.10 0.00 01:00:00

(DEL AM)

18/10/2016 11:04am

Edgar (US Regulatory)


 

Austin Legal Group, APC

 

 

 

 

 

 

 

 

Lawyers

3990 Old Town Ave, Ste A-112

San Diego, CA 92110

 

Licensed in California & Hawaii & Arizona

Telephone

(619) 924-9600

 

Facsimile

(619) 881-0045

 

 

 

 

 

 

 

 

Writer’s Email:

gaustin@austinlegalgroup.com

 

October 17, 2016

 

Suzanne Hayes

Assistant Director

Office of Healthcare and Insurance

Division of Corporation Finance

 

  Re: Immune Therapeutics, Inc.
    Delaying Amendment to Registration Statement on Form S-1
    Filed October 14, 2016
    CIK No. 0001559356

 

Ms. Hayes:

 

Pursuant to Rule 473 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Immune Therapeutics, Inc. (the “Registrant”), is hereby filing a delaying amendment with respect to the above-captioned Registration Statement which was filed with the Securities and Exchange Commission (the “Commission”) on October 14, 2016 (the “Registration Statement”). Accordingly, the following is hereby incorporated immediately following the calculation of the registration fee table and its footnotes on the cover page of the registration statement:

 

“The Registrant hereby amends the Registration Statement on such date or dates as may be necessary to delay its effective date until the Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Act or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to Section 8(a), may determine.”

 

  Very truly yours,
   
  AUSTIN LEGAL GROUP, APC
   
 
  Gina M. Austin

 

     
   

1 Year Immune Therapeutics (PK) Chart

1 Year Immune Therapeutics (PK) Chart

1 Month Immune Therapeutics (PK) Chart

1 Month Immune Therapeutics (PK) Chart

Your Recent History

Delayed Upgrade Clock